LINGO1 antisense RNA 1 (LINGO1-AS1)

LINGO1 antisense RNA 1 (LINGO1-AS1) is a long non-coding RNA transcribed from the antisense strand of the LINGO1 gene locus. Like other antisense lncRNAs, it is presumed to participate in the regulation of its sense gene (LINGO1), potentially by mechanisms such as modulation of transcription, RNA stability, or epigenetic modifications. There is no published evidence to date classifying LINGO1-AS1 as a conventional receptor, enzyme, or therapeutic target. Its specific biological functions, disease roles, and clinical relevance remain to be demonstrated. General mechanisms for antisense lncRNAs include stabilizing or destabilizing the mRNA of the associated sense gene, recruiting chromatin regulatory proteins, or acting as molecular sponges for microRNAs. No results were found linking LINGO1-AS1 to any directly interacting drugs, nor is it currently established as a biomarker or a clinically actionable therapeutic target. If you were seeking information on LINGO1 (leucine-rich repeat and immunoglobin-like domain-containing protein 1), which is a therapeutic target and a receptor involved in neurodegeneration and myelination, please clarify—most available therapeutic and disease literature pertains to LINGO1, not LINGO1-AS1.

Other names

LINGO1-AS1

Not applicable (no drugs known to interact with this RNA; general mechanisms for antisense lncRNAs can include modulation of sense gene expression via RNA:RNA pairing, recruitment of chromatin modifiers, or acting as a competing endogenous RNA)